-
Protein kinase C(theta) in T cell activation.
Annu Rev Immunol. 2002;20:761-94
PMID: 11861617
-
The inhibition of metalloproteinases as a therapeutic target in rheumatoid arthritis and osteoarthritis.
Curr Opin Pharmacol. 2001 Jun;1(3):314-20
PMID: 11712757
-
The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors.
J Cell Biol. 2002 Jul 22;158(2):221-6
PMID: 12119356
-
Intramembrane proteolysis controls diverse signalling pathways throughout evolution.
Curr Opin Genet Dev. 2002 Oct;12(5):512-8
PMID: 12200155
-
Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3).
Eur J Immunol. 2002 Aug;32(8):2255-63
PMID: 12209638
-
Metalloproteinase inhibitors: biological actions and therapeutic opportunities.
J Cell Sci. 2002 Oct 1;115(Pt 19):3719-27
PMID: 12235282
-
TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity.
J Clin Invest. 2002 Sep;110(6):835-42
PMID: 12235115
-
The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts.
Hum Mol Genet. 2002 Oct 1;11(21):2615-24
PMID: 12354787
-
Metalloproteinase shedding of Fas ligand regulates beta-amyloid neurotoxicity.
Curr Biol. 2002 Sep 17;12(18):1595-600
PMID: 12372252
-
Cutting edge: molecular analysis of the negative regulatory function of lymphocyte activation gene-3.
J Immunol. 2002 Nov 15;169(10):5392-5
PMID: 12421911
-
The ADAMs family of metalloproteases: multidomain proteins with multiple functions.
Genes Dev. 2003 Jan 1;17(1):7-30
PMID: 12514095
-
The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells.
Eur J Immunol. 2003 Apr;33(4):970-9
PMID: 12672063
-
Biochemical properties and functions of membrane-anchored metalloprotease-disintegrin proteins (ADAMs).
Curr Top Dev Biol. 2003;54:101-23
PMID: 12696747
-
Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling.
EMBO J. 2003 Jun 2;22(11):2704-16
PMID: 12773386
-
Protein kinase C theta affects Ca2+ mobilization and NFAT cell activation in primary mouse T cells.
J Exp Med. 2003 Jun 2;197(11):1525-35
PMID: 12782715
-
Inactivating mutations block the tumor necrosis factor-alpha-converting enzyme in the early secretory pathway.
Biochem Biophys Res Commun. 2004 Feb 20;314(4):1028-35
PMID: 14751236
-
Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.
J Cell Biol. 2004 Mar 1;164(5):769-79
PMID: 14993236
-
Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo.
J Immunol. 2004 May 1;172(9):5450-5
PMID: 15100286
-
Gamma-secretase: proteasome of the membrane?
Nat Rev Mol Cell Biol. 2004 Jun;5(6):499-504
PMID: 15173829
-
Loss of ectodomain shedding due to mutations in the metalloprotease and cysteine-rich/disintegrin domains of the tumor necrosis factor-alpha converting enzyme (TACE).
J Biol Chem. 2004 Jun 25;279(26):27365-75
PMID: 15075334
-
Matrix metalloproteinases as modulators of inflammation and innate immunity.
Nat Rev Immunol. 2004 Aug;4(8):617-29
PMID: 15286728
-
Role of LAG-3 in regulatory T cells.
Immunity. 2004 Oct;21(4):503-13
PMID: 15485628
-
LAG-3, a novel lymphocyte activation gene closely related to CD4.
J Exp Med. 1990 May 1;171(5):1393-405
PMID: 1692078
-
Protein kinase C forms a complex with and phosphorylates the GTPase activating protein GAP: phosphorylation by PKC is dependent on tyrosine phosphorylation of GAP and/or a GAP-associated protein.
Biochem Biophys Res Commun. 1993 Jul 15;194(1):571-6
PMID: 7687440
-
Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.
J Clin Invest. 1994 Dec;94(6):2177-82
PMID: 7989572
-
Transforming growth factor-alpha and beta-amyloid precursor protein share a secretory mechanism.
J Cell Biol. 1995 Feb;128(3):433-41
PMID: 7844156
-
A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.
Nature. 1997 Feb 20;385(6618):729-33
PMID: 9034190
-
Characterization of the major histocompatibility complex class II binding site on LAG-3 protein.
Proc Natl Acad Sci U S A. 1997 May 27;94(11):5744-9
PMID: 9159144
-
Genomic organization of the human LAG-3/CD4 locus.
Immunogenetics. 1997;47(1):96-8
PMID: 9382927
-
Regulation of expression of the human lymphocyte activation gene-3 (LAG-3) molecule, a ligand for MHC class II.
Immunogenetics. 1998 Jul;48(2):116-24
PMID: 9634475
-
An essential role for ectodomain shedding in mammalian development.
Science. 1998 Nov 13;282(5392):1281-4
PMID: 9812885
-
ADAMs: focus on the protease domain.
Curr Opin Cell Biol. 1998 Oct;10(5):654-9
PMID: 9818177
-
Profound enhancement of T cell activation mediated by the interaction between the TCR and the D3 domain of CD4.
J Immunol. 1999 Feb 1;162(3):1431-9
PMID: 9973399
-
Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3922-7
PMID: 10097139
-
Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes.
Cell. 1999 Apr 2;97(1):133-44
PMID: 10199409
-
Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223).
J Immunol. 2004 Dec 1;173(11):6806-12
PMID: 15557174
-
Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223).
J Immunol. 2005 Jan 15;174(2):688-95
PMID: 15634887
-
ADAMs: key components in EGFR signalling and development.
Nat Rev Mol Cell Biol. 2005 Jan;6(1):32-43
PMID: 15688065
-
ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling.
EMBO J. 2005 Feb 23;24(4):742-52
PMID: 15692570
-
ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation.
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9182-7
PMID: 15958533
-
Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans.
Cell. 2005 Oct 21;123(2):291-304
PMID: 16239146
-
Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.
Nat Rev Cancer. 2006 Mar;6(3):227-39
PMID: 16498445
-
ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23.
Nat Immunol. 2006 Dec;7(12):1293-8
PMID: 17072319
-
Protein kinase ctheta cooperates with calcineurin to induce Fas ligand expression during activation-induced T cell death.
J Immunol. 1999 Dec 1;163(11):5813-9
PMID: 10570264
-
Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme.
J Biol Chem. 2000 May 12;275(19):14608-14
PMID: 10799547
-
A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE.
Mol Cell. 2000 Feb;5(2):207-16
PMID: 10882063
-
TNFRSF1A mutations and autoinflammatory syndromes.
Curr Opin Immunol. 2000 Aug;12(4):479-86
PMID: 10899034
-
Alzheimer's disease. A partner for presenilin.
Nature. 2000 Sep 7;407(6800):34-5
PMID: 10993060
-
Requirements for presenilin-dependent cleavage of notch and other transmembrane proteins.
Mol Cell. 2000 Sep;6(3):625-36
PMID: 11030342
-
Development of matrix metalloproteinase inhibitors in cancer therapy.
J Natl Cancer Inst. 2001 Feb 7;93(3):178-93
PMID: 11158186
-
Protein kinase C-theta;: signaling from the center of the T-cell synapse.
Curr Opin Immunol. 2002 Jun;14(3):323-30
PMID: 11973130